Getting ahead of avian influenza: Why organizations need to prepare today

Highly Pathogenic Avian Influenza A(H5N1), commonly referred to as bird flu, has been making headlines around the world, as the virus rapidly spreads to new animal species. Already the cause of a panzootic (global animal pandemic), last month a human H5N1 case was reported in the U.S. after likely contracting it from infected dairy cattle. The virus […]

Navigating the pandemic: Unveiling the impact of non-pharmaceutical interventions and vaccines

The Institute for Pandemics (IfP) presents a webinar to discuss the impact of both non-pharmaceutical (NPI) interventions and vaccine uptake in Canada during the COVID-19 pandemic. Dr. Paul Grootendorst (Leslie Dan Faculty of Pharmacy) will provide a descriptive overview of the provincial pandemic responses and mortality and economic outcomes. Following his presentation, there will be a panel […]

Uncovering mpox: The underestimated crisis and its international spread

The mpox outbreak has surged into a Public Health Emergency of International Concern (PHEIC), with the real crisis potentially worse than the official reports suggest. Undetected cases are spreading swiftly beyond Africa, as this threat remains largely unchecked. The international community is lagging in the fight against mpox. BlueDot founder and CEO and EPIC member, […]

The Microbiome from Planetary to Microbial Scale

The Gairdner Foundation hosts its Global Perspectives Panel: The Microbiome from Planetary to Microbial Scale. Join the virtual event for a full-scale survey of the role of the microbiome in human health and the role of humans in a microbial world. Leading experts Brett Finlay, Amber Benezra and Samira Mubareka (EPIC member) join Gairdner Early Career Investigators Sarah Elton, Abiola […]

Vaccines in Older Individuals: Barriers to uptake and possible solutions

Virtual on Zoom

Join EPIC faculty member Allison McGeer (Mount Sinai Hospital), and speakers Christine Fahim (St. Michael’s Hospital) and Melissa Andrew (Dalhousie University) in this Centre for Vaccine Preventable Diseases (CVPD) hosted webinar. Presentations will explore the reasons for sub-optimal immunization coverage for older adults in Canada, including complex eligibility criteria, access issues, hesitancy from older individuals […]

Emerging pathogen threats: Strategies for infection prevention & control

The landscape of infectious diseases is rapidly evolving, presenting new challenges for governments, enterprise organizations, and particularly those in the infection prevention space. Hosted by BlueDot, this webinar offers an updated list of high-consequence pathogens that require attention and aims to provide the knowledge and tools necessary to address emerging threats and enhance infection control […]

Soft Skills Training for Graduate Students: Building Your Online Presence and Personal Brand

This webinar will cover how graduate students doing research can leverage social media platforms to build a successful online presence, engage with a broad audience, and communicate their research responsibly and effectively. Topics include practical guidelines for building a personal brand, using social media effectively, and leveraging AI tools as well as best-practice examples and […]

PHO Microbiology Rounds: Building Pediatric Infectious Disease Observatory

Organized by Public Health Ontario (PHO) the PHO: Microbiology Rounds webinar series is featuring a presentation by U of T alum, Senjuti Saha. Senjuti Saha obtained her PhD from the UofT Department of Molecular Genetics and did post-doctoral training at Toronto’s SickKids Research Institute and then at Stanford U. Since 2016, she has pioneered genomics […]

Mpox vaccination in Ontario: clinical, community, and research perspectives

The 2022 outbreak of mpox in Canada disproportionately affected gay, bisexual, and other men who have sex with men (GBMSM). Recognizing that the GBMSM group is at high risk of exposure, Ontario deployed the two-regimen modified vaccinia ankara–bavaria nordic (MVA-BN) vaccine, first in June 2022 and next in September 2022. Vaccine uptake, however, has remained […]

Opportunities for prevention: Group B Streptococcus vaccines under development

Virtual

Group B Streptococcus (GBS) causes serious and fatal infections in newborns and is the leading cause of neonatal sepsis and meningitis. In this webinar co-hosted by the Centre for Vaccine Preventable Diseases, Eliana Castillo, Kirsty Le Doare and Ziyaad Dangor will discuss the latest clinical findings on GBS vaccine candidates and outline a path to […]